Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!

The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.

Importance of New Treatment Option

"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.

Symbravo Trial Results, How Was It Approved

The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.

While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.

And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.

Tech entrepreneur Bryan Johnson is expanding his horizons in longevity health experiments to female physiology, including monitoring his girlfriend Kate Tolo’s nighttime clitoral engorgement.

The purpose is to understand how genital blood flow may give clues about female sexual function and cardiovascular health.

The experiment is part of his extensive effort to collate data on women’s health that could be channeled into useful biomarkers.

But while research suggests a connection between genital blood flow, sexual arousal and cardiometabolic health, tracking these changes during sleep may not be an established way to screen heart disease.

Bryan Johnson Is Tracking His Girlfriend's Clitoral Blood Flow

Bryan Johnson and Kate Tolo are in the process of creating a detailed health-monitoring program through their company, Immortals. Their aim is to improve in-depth understanding of female physiology.

The process is partly inspired by research on erectile dysfunction in men. As erections depend on healthy blood vessels, erectile dysfunction can sometimes help in the detection of cardiovascular disease.

In an interview discussing the project, Tolo explained the reasoning behind investigating genital blood flow in women. “Because the penis has smaller blood vessels than the rest of the body, and so it's the first thing to show up when problems happen. So it's all about blood flow. That's why it should work for women just as well as it works for men, because we have blood vessels too,” she said. Johnson also highlighted nighttime erections as a physiological measure worth studying.

However, the evidence linking male erectile dysfunction with cardiovascular risk is more established than the evidence for using female genital blood flow measurements as a cardiovascular monitoring tool.

Also read: Bryan Johnson Blames Sugary Cereals, Soda and Stress for His Autoimmune Disease; Shares Treatment Plan

What Does Clitoral Engorgement Reveal About Sexual Health?

The clitoris contains erectile tissue supplied by blood vessels. During sexual arousal, increased blood flow contributes to genital engorgement and physiological changes associated with sexual response.

Blood circulation is therefore one component of sexual function. Reduced genital blood flow or increased vascular resistance may be associated with difficulties involving arousal, lubrication or orgasm.

A small pilot study published in the International Journal of Impotence Research examined 27 women and found that clitoral tissue perfusion was linked with scores measuring sexual function, including arousal, lubrication, orgasm and satisfaction.

The findings indicate that genital blood supply may be relevant to understanding female sexual health. However, the study was small and did not establish that nighttime clitoral blood-flow monitoring can diagnose sexual dysfunction.

Sexual function is also influenced by hormones, medications, neurological health, psychological factors, relationships and underlying medical conditions. Blood flow alone cannot explain every aspect of sexual wellbeing.

Also read: Bryan Johnson's 90-Day Experiment Claims That Oxygen Therapy Could Beat Aging

Can Clitoral Blood Flow Reveal Cardiovascular Risk?

The endothelium, the inner lining of blood vessels, helps regulate circulation. Metabolic conditions like diabetes, insulin resistance, high cholesterol, and hypertension can affect vascular function, including genital tissues.

A 2024 review published in the European Journal of Preventive Cardiology, which included 54 studies and nearly 149,000 participants, also found that women with cardiovascular disease had a higher risk of female sexual dysfunction.

This supports a relationship between cardiovascular and sexual health, but it does not validate Johnson’s tracking method.

Nocturnal genital responses may provide useful information about physiology, but researchers would need to establish what constitutes a normal pattern, how measurements vary with sleep and hormonal cycles, and whether particular changes reliably predict disease. The approach would also need to be tested in larger populations.

Pope Leo XIV has announced that he will undergo surgery in the coming days to have a nodule removed that was discovered in his lung recently. The 71-year-old pontiff said it was detected early and was well contained, which is why the doctors recommended a removal procedure.

The Vatican has not disclosed whether the nodule is benign or cancerous. The procedure has nevertheless sparked attention to lung nodules, a common medical finding that can sometimes warrant further clinical investigation to rule out cancer and other serious diseases.

“Recently, during some medical examinations, doctors found a localized nodule in my lung,” the pope said during his Sunday address in St. Peter’s Square on October 11. “It was detected at a very early stage and is well contained.”

He added, “The doctors believe it is advisable to intervene, so, following their advice, I have decided to undergo surgery to remove it. The operation is already scheduled for the next few days.” The Vatican said the pope’s recovery may take about a week.

What Is A Lung Nodule?

Also read: Lung Nodule on CT Scan? Doctors Explain When You Should Worry

Dr. Vinayak Maka, Senior Oncologist, Department of Oncology, Ramaiah Memorial Hospital told HealthandMe, "A lung nodule is a small, round or oval-shaped growth in the lung, typically less than 3 cm in size, most often discovered incidentally during a chest X-ray or CT scan done for an unrelated reason."

According to the American Thoracic Society, lung nodules may develop because of scar tissue, a previous lung infection or irritation. In a few cases, however, a nodule may be an early sign of lung cancer. Most lung nodules are benign.

"A lung nodule finding on a CT scan often triggers panic, but the reality is reassuring. Over 95% of lung nodules are benign, arising from old infections, scars, or inflammation. Still, understanding when a nodule warrants concern can be lifesaving." Dr. Vinayak Maka added.

When Does A Lung Nodule Need To Be Removed?

Also read: Sharmila Tagore’s Stage Zero Lung Cancer: Can Surgery Prevent Progression?

Doctors assess the nodule's size, shape, location, and appearance on imaging, along with the patient’s medical history and other risk factors.

Not every lung nodule requires surgery. Many are monitored through repeat CT scans to determine whether they remain stable or grow over time. Doctors may recommend additional testing or removal when:

• The nodule grows: An increase in size on follow-up scans can raise suspicion of cancer and prompt further investigation. Doctors say nodules smaller than 6 mm have a very low cancer risk (under 1%) and usually only need routine follow-up. Those measuring 6–8 mm carry a slightly higher risk (1–2.5%) and are typically monitored with a repeat CT scan after 6–12 months.

• Its appearance is concerning: Certain shapes, edges or other imaging features may make a nodule more suspicious.

• Risk factors: Older age, history of smoking, family history of lung cancer, and past exposure to substances like asbestos may be considered.

• Imaging is inconclusive: When the possibility of cancer remains significant, obtaining tissue for examination may be necessary.

• The nodule is considered sufficiently suspicious for cancer: If the risk is high, doctors may recommend surgical removal rather than relying on monitoring or a less invasive biopsy.

The decision also depends on the nodule’s location, whether it can be reached safely for a biopsy and the patient’s overall health. Surgery may provide both a confirmed diagnosis and treatment if the growth proves to be an early-stage cancer.

Stephen Liu, a lung cancer specialist at Georgetown University in Washington and division chief of haematology-oncology at MedStar Georgetown University Hospital, explained the role of surgery in such cases.

“When there is sufficient concern, and when it is safe to do so, based on the location of the nodule and the overall health of the patient, surgical removal can provide a definitive diagnosis,” he said.

Pope Leo said his lung nodule was detected at a very early stage. His planned surgery is therefore a decision made by his treating doctors based on information that has not been made public.

Italian Prime Minister Giorgia Meloni expressed support for the pontiff, saying, “I would like to express to the Holy Father my personal support, and that of the Italian government, as he faces this challenge in the coming days.”

She added, “The serenity and composure with which he spoke about it during today’s Angelus are reassuring."

Scrub typhus has claimed 15 lives at Jaipur's Sawai Man Singh (SMS) Hospital between July and September, raising concerns about the fatal infection that can be mistaken as common illnesses like dengue, malaria and typhoid.

According to reports, the hospital recorded more than 323 admissions from January to September. September alone accounted for 213 cases and nine deaths. According to the doctors, many of the deaths are attributed to organ failure, highlighting the importance of early diagnosis and treatment.

What Is Scrub Typhus And How Is It Transmitted?

Scrub typhus is a bacterial infection caused by Orientia tsutsugamushi. It spreads through the bite of infected larval mites, commonly called chiggers, which are found in grassy areas, fields, bushes and vegetation.

Humans can become infected while working in agricultural fields or getting exposed in areas where these mites thrive. Scrub typhus does not ordinarily spread directly from one person to another. Symptoms usually develop around one to three weeks after exposure but the period of incubation can vary.

Also read: Plague Treatable, CDC Monitoring US Arrivals From Russia After Worker’s Death, Says Director Erica Schwartz

Symptoms Of Scrub Typhus

Early symptoms can be difficult to distinguish from other infections. They may include:

• Fever and chills
• Headache
• Body aches and fatigue
• Skin rash
• Swollen lymph nodes
• Burning sensation in eyes
• Dry cough

Another important symptom is an eschar, a dark, scab-like mark that may develop at the site of a mite bite. It can resemble a small burn or black crust, which is often surrounded by redness. However, not every infected person develops this mark, so its absence does not rule out the infection.

Dr Vishal Gupta, a professor in the Department of Medicine at SMS Hospital, said that people should be alert if they develop any of the aforementioned symptoms of scrub typhus.

The disease is transmitted through bites from mites or fleas. It is therefore important to wear full-sleeved clothing while working in fields and use an insect-repellent cream.

Also read: Russia Plague Scare: WHO Reiterates Biosafety Rules Despite No Confirmed Lab Accident

When Can Scrub Typhus Become Fatal?

If treatment is delayed, the infection can progress towards serious complications, including inflammation of the lungs, liver and brain, kidney injury, bleeding and multiple-organ failure.

As its early symptoms may overlap with those of dengue, malaria and other febrile illnesses, diagnosis may be delayed. People with persistent fever, especially after exposure to fields or dense vegetation, should seek medical assessment and mention the relevant exposure to their doctor.

Scrub typhus is treatable with antibiotics. Doxycycline is the preferred treatment in many cases, and early treatment can reduce the risk of severe complications. Doctors may choose alternative antibiotics depending on factors like pregnancy, age and the patient's clinical history.

Treatment should be prescribed by a healthcare professional. Patients should not self-medicate with antibiotics or wait for symptoms to become severe before seeking care.

How Can You Prevent Scrub Typhus?

There is currently no widely available vaccine for scrub typhus, making exposure prevention important.

• Wear long sleeves, long trousers and covered footwear when visiting fields or areas with dense vegetation.
• Use an appropriate insect repellent according to its label.
• Avoid sitting or lying directly on grass or scrub vegetation.
• Shower and change clothes after spending time in potentially infested areas.
• Seek prompt medical care if fever develops after possible exposure.